Home / Science / Mind Meets Machine: New Brain Interface Trials Begin
Mind Meets Machine: New Brain Interface Trials Begin
14 Apr
Summary
- Top neurobiologist joins startup for human brain interface trials.
- Biohybrid sensor combines lab-grown neurons with electronics.
- Company aims to treat disease and enhance human senses.
Science Corporation, a startup co-founded by Max Hodak, is preparing for the first US human trials of its biohybrid brain-computer interface. Dr. Murat Günel, chair of neurosurgery at Yale Medical School, has joined as a scientific adviser to lead the surgical implantation of a novel sensor.
This biohybrid interface aims to merge lab-grown neurons with electronic components. Unlike traditional electrodes that can cause brain damage, Science's approach uses stimulated neurons to naturally integrate with the brain, forming a biological bridge. Initial trials will test the sensor's safety and efficacy in measuring brain activity in patients requiring brain surgery.
The company has also developed PRIMA, a device for restoring vision, which is nearing European regulatory approval. Hodak's broader vision for Science Corporation extends to enhancing human capabilities, such as adding new senses.
Günel anticipates that successful trials could lead to treatments for conditions like Parkinson's disease by potentially halting disease progression. While optimistic, he estimates trials could begin as early as 2027.
